Journal article · 2014

Pharmacogenomics: Promise and limits of personalized drug therapy

Wolfgang Sadée

Clinical Pharmacology & Biopharmaceutics · Published 17 December 2014

View at the publisherCite this paper

In brief

“Pharmacogenomics: Promise and limits of personalized drug therapy” is a 2014 journal article by Wolfgang Sadée, published in Clinical Pharmacology & Biopharmaceutics. OpenAlex counts 0 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
1

Abstract

P plays an increasing role in disease prevention, and therapy. While substantial adverse reactions and insufficient efficacy continue to limit significantly the benefits of drug therapy, an understanding of the underlying causes of varying drug response has the potential to improve outcomes substantially. Much evidence supports the hypothesis that genetic factors play a critical role… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sadée, W. (2014). Pharmacogenomics: Promise and limits of personalized drug therapy. Clinical Pharmacology & Biopharmaceutics. https://www.omicsonline.org/2167-065X/2167-065X.S1.006-013.pdf

MLA 9

Sadée, Wolfgang. “Pharmacogenomics: Promise and limits of personalized drug therapy.” Clinical Pharmacology & Biopharmaceutics, 2014. https://www.omicsonline.org/2167-065X/2167-065X.S1.006-013.pdf.

Chicago

Sadée, Wolfgang. 2014. “Pharmacogenomics: Promise and limits of personalized drug therapy.” Clinical Pharmacology & Biopharmaceutics. https://www.omicsonline.org/2167-065X/2167-065X.S1.006-013.pdf.

Harvard

Sadée, W. (2014) ‘Pharmacogenomics: Promise and limits of personalized drug therapy’, Clinical Pharmacology & Biopharmaceutics. Available at: https://www.omicsonline.org/2167-065X/2167-065X.S1.006-013.pdf.

IEEE

W. Sadée, “Pharmacogenomics: Promise and limits of personalized drug therapy,” Clinical Pharmacology & Biopharmaceutics, 2014.

BibTeX

@article{sadee2014pharmacogenomics,
  title     = {{Pharmacogenomics: Promise and limits of personalized drug therapy}},
  author    = {Sadée, Wolfgang},
  journal   = {Clinical Pharmacology \& Biopharmaceutics},
  year      = {2014},
  url       = {https://www.omicsonline.org/2167-065X/2167-065X.S1.006-013.pdf}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • individualized drug therapy
  • pharmacogenetics
  • genetic variants
  • clinical biomarkers
  • drug response variability
  • adverse drug reactions
  • epigenome

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Sadée, W. (2014). Pharmacogenomics: Promise and limits of personalized drug therapy. Clinical Pharmacology & Biopharmaceutics. https://www.omicsonline.org/2167-065X/2167-065X.S1.006-013.pdf

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Wolfgang Sadée.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.